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ABSTRACT
Objectives: To examine 10-year mortality and hospital
use among individuals categorised as resilient and
vulnerable to the impact of chronic pain.
Design: A cohort record linkage study.
Setting: Grampian, Scotland.
Participants: 5858 individuals from the Grampian Pain
Cohort, established in 1996, were linked, by probability
matching, with national routinely collected datasets.
Main outcome measures: HRs for subsequent 10-
year mortality and ORs/incidence rate ratios for
subsequent 10-year hospital use, each with adjustment
for potential confounding variables.
Results: 36.5% of those with high pain intensity
reported a low pain-related disability (categorised
resilient) and 7.1% of those reporting low pain intensity
reported a high pain-related disability (categorised
vulnerable). Sex, age, housing, employment and long-
term limiting illness were independently associated with
being vulnerable or resilient. After adjustment for these
variables, individuals in the resilient group were 25%
less likely to die within 10 years of the survey compared
with non-resilient individuals: HR 0.75, 95% CI 0.62 to
0.91 and vulnerable individuals were 45% more likely to
die than non-vulnerable individuals: HR 1.45, 95% CI
1.01 to 2.11. Resilient individuals were less likely to
have had an outpatient or day-case visit for
anaesthetics: OR 0.46, 95% CI 0.27 to 0.79, but no
other clinical specialities. Vulnerable individuals were
significantly less likely to have had any outpatient or
day-case visit (OR 0.43, 0.25 to 0.75); but more likely
to have had a psychiatric visit (OR 1.96, 1.06 to 3.61).
No significant differences in likelihood of any inpatient
visits were found.
Conclusions: Resilient individuals have a better 10-
year survival than non-resilient individuals indicating
that resilience is a phenomenon worth researching.
Further research is needed to explore who is likely to
become resilient, why and how, as well as to tease out
the internal and external factors that influence resilience.
INTRODUCTION
Chronic pain is common.1–3 It has wide-
reaching physical, psychological and social
consequences3–7 and places a heavy burden
on individuals, society and healthcare ser-
vices.8 9 While much clinical practice and
research focuses on those who perform badly
with a condition (‘vulnerable’ individuals),
interest is growing in understanding the
characteristics and experiences of those who
appear to perform well (‘resilient’ indivi-
duals).10 11 Recent studies have examined
resilience to physical illness,12 menopausal
symptoms13 and speciﬁc conditions such as
diabetes,14 epilepsy,15 asthma16 and chronic
pain.17–22 These studies have provided useful
insights into the short-term importance of
resilience. They have also indicated some of
the factors accounting for why certain
people appear to cope better with their con-
dition than others, such as socioeconomic
factors, individual personality traits, psycho-
logical factors, spirituality, social support and
general health. Little is known, however,
about the long-term outcomes of resilient
and vulnerable individuals. Such information
is needed to understand the clinical and
research relevance of trying to identify both
sets of individuals.
In this article, we linked information about
respondents to a large community-based
survey with routinely collected health service
Strengths and limitations of this study
▪ This is the first study to examine the long-term
effects of resilience or vulnerability to chronic
pain in terms of survival and hospital use.
▪ A major strength of our study was its community
base, meaning results from this study are more
likely to be representative of people living in the
community than those from studies using
samples from healthcare settings, such as pain
clinics.
▪ The prospective nature of the study meant that
pain status was ascertained before outcome was
measured, avoiding a recall bias.
▪ We did not use a formal resilience measurement
scale. Instead, we categorised individuals on the
basis of their scores on the intensity and disabil-
ity subscales of a chronic pain measure.
▪ Although we were able to adjust for several
sociodemographic variables in the analysis,
some other potentially important factors were
not fully available in the dataset (eg, smoking).
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data to examine long-term (10 years) hospital use and
mortality among those categorised as resilient and vul-
nerable to the impact of chronic pain. Our hypothesis
was that those categorised as resilient would fare better
than a comparison group with a similar level of chronic
pain, and those categorised as vulnerable would
perform worse.
METHODS
Grampian cohort
The Grampian cohort, established in July 1996,2 com-
prised 6940 adults (aged 25+ years) recruited from 29
practices across Grampian, North East Scotland. These
included 3605 individuals recruited through random
selection from everyone registered with the practice
(essentially a general population sample) and 3335 indi-
viduals recruited through random selection based on
those receiving repeat prescriptions for analgesic use.
Full details of the survey have been reported previ-
ously.23 Brieﬂy, participants were sent a postal question-
naire in 1996 which included questions about the
presence and severity of chronic pain and a range of
items regarding health and sociodemographic details.
The corrected response rate was 84.3% after two remin-
ders. The study respondents were broadly representative
of the Grampian population.7
Chronic pain status
Individuals with chronic pain were identiﬁed by afﬁrma-
tive answers to two questions based on the International
Study for the Association of Pain (IASP) deﬁnition24:
(1) Are you currently troubled by pain or discomfort,
either all the time or on and off? (2) Have you had this
pain or discomfort for more than 3 months?
Pain severity
Chronic pain severity was assessed using the Chronic
Pain Grade (CPG) questionnaire.25 This is a seven-item
instrument that measures severity in two dimensions:
intensity subscale (three visual analogue scale items:
current, worst and average pain intensity in the last
6 months) and disability subscale (three visual analogue
scale items: interference with daily activities, social activ-
ities and daily work in the last 6 months and one item
on number of days off work). A score is generated from
the three visual analogue scale items for each subscale,
from 0 (best possible pain state) to 100 (worst possible
pain state). These scores and the item on number of
days off work are then used to classify chronic pain into
four hierarchical grades, from grade I (low-disability, low-
intensity pain) to grade IV (high-disability, severely limit-
ing pain). The CPG has been shown to be valid and reli-
able for use in a self-completion postal questionnaire in
the UK general population.26 Only those who gave
afﬁrmative answers to both of the chronic pain questions
were asked to complete the CPG questionnaire.
General health and socioeconomic details
The questionnaire included several questions about
general health. For this paper, we used the results from
a question on the presence or absence of a long-term
limiting illness drawn from the National Census (http://
www.gro-scotland.gov.uk/ﬁles/hseform.pdf). The ques-
tionnaire also included items regarding sex, age, marital
status, education, housing, social support and employ-
ment status.
National routinely collected datasets
In Scotland, routinely collected health information and
statistics are collated and stored in a national database by
the Information Services Division (ISD), National Health
Service (NHS) Scotland (http://www.isdscotland.org/
isd/1.html). These routinely collected national datasets
can be linked with existing cohorts where adequate per-
sonal details are available. An advantage of using national
datasets is the ability to follow-up the members of a
cohort who remain in Scotland but who move away from
their recruitment location. Data (from 1996 to 2006
inclusive) about respondents to the Grampian survey
were requested from four of the national datasets: the
General Register Ofﬁce death records; SMR00—ﬁrst
attendances at outpatient clinics; SMR01—inpatient and
day-case episodes in general and acute wards of hospitals
and SMR04—inpatient and day cases in psychiatric units
and hospitals.
Record linkage
A copy of the Grampian cohort dataset was forwarded to
the Medical Records Linkage Team at ISD who under-
took the linkage. ISD-held data were linked using stand-
ard probability matching procedures based on common
patient identiﬁable ﬁelds. The new linked dataset was
stripped of patient identiﬁers by ISD and returned to
the research team in an anonymised format. This
approach enabled detailed analysis of the linked data,
while maintaining the patient’s conﬁdentiality.
Identification of resilient and vulnerable individuals
Individuals were categorised into one of four groups
based on their scores on the intensity and disability sub-
scales of the CPG. Individuals with a low pain-related dis-
ability (<50/100) despite a high-intensity pain (≥50/
100) were categorised as ‘resilient’; these individuals
were compared with ‘non-resilient’ individuals who
reported a high pain-related disability (≥50/100) and
high-intensity pain (≥50/100). Individuals with a high
pain-related disability (≥50/100) in spite of a low-
intensity pain (<50/100) were categorised as ‘vulner-
able’; these individuals were compared with ‘non-
vulnerable’ individuals who reported a low-intensity pain
(<50/100) and low pain-related disability (<50/100).
Grouping of hospital-related data
Routine data were available for 42 different clinical spe-
cialities and included the number of visits (as outpatient
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or day-case) and the total number of days spent as an
inpatient, for each speciality. In order to maximise our
statistical power, we pooled the different visit types and
collapsed the data into six categories: (1) medicine
(general medicine, geriatric medicine, all major medical
specialities except rheumatology), (2) surgery (general
surgery, all surgical specialities, eg, ear, nose and
throat, gynaecology, but excluding orthopaedic surgery);
(3) musculoskeletal (rheumatology and orthopaedic
surgery); (4) anaesthetics (as pain clinics are coded by
this speciality); (5) oncology (including palliative care
and haematology) and (6) psychiatry. Full details of the
categorisation are in online supplementary appendix
1. Information about use of accident and emergency ser-
vices, which are largely accessed in an unscheduled way,
was not available since the datasets requested relate to
scheduled care.
Statistical analysis
The data were analysed using SPSS for Windows (V.19)
and R 2.15.2. Descriptive statistics examined the propor-
tion of people categorised as resilient or vulnerable.
Binary logistic regression was then used to examine the
demographic, socioeconomic and health factors asso-
ciated with being in each group. In each case, resilient
individuals were compared with those in the non-
resilient comparison group and those in the vulnerable
group were compared with those in the non-vulnerable
comparison group.
Cox regression survival analysis was conducted to obtain
unadjusted and adjusted HR with 95% CI for all-cause
mortality and cause of death. Adjustments were made for
factors independently associated with being vulnerable or
resilient on multivariate analysis. The assumption of con-
stant time-dependent covariates was checked for each
model and found to hold.
Hospital use was analysed using a two-stage procedure
to test for differences in binary (any visits or none) and
continuous (number of visits in those having at least one
visit) components. In view of overdispersion in the data,
we used negative binomial regression for the continuous
component with logistic regression for the binary com-
ponent. The results were expressed as OR for the binary
component and incidence rate ratios for the continuous
component.
Sensitivity analyses were conducted to explore how our
ﬁndings changed if: (1) pain-related disability was mea-
sured in a different way; and (2) we adjusted for add-
itional factors with incomplete data.
RESULTS
ISD managed to link 5858 (84.4%) of the 6940 indivi-
duals in the original Grampian cohort. The character-
istics of the linked cohort were very similar to the
original complete cohort with no signiﬁcant differ-
ences in demographic, socioeconomic or pain factors.
A total of 4139 (70.7%) of those in the linked cohort
had chronic pain at baseline of which 3739 (90.3%)
had detailed information on pain intensity and disabil-
ity and were included in subsequent analyses
(see ﬁgure 1).
Figure 1 Flow chart depicting
study process.
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Resilience and vulnerability
Of the 2242 individuals reporting high-intensity pain, 819
(36.5%) reported low pain-related disability and were
categorised as resilient, while 1423 (63.5%) reported
high pain-related disability and were categorised as non-
resilient. Among the 1497 individuals reporting low
intensity pain, 107 (7.1%) had high pain-related disability
and so were categorised as vulnerable, compared with
1390 (92.9%) who reported low pain-related disability
and were categorised as non-vulnerable.
Factors associated with being resilient and vulnerable
Table 1 presents the measured demographic, socio-
economic and health factors associated with being in
the resilient and vulnerable groups. On univariate ana-
lysis, individuals were less likely to be classiﬁed as resili-
ent to their chronic pain if they were women, older, no
longer married, had less than an university education,
lived in rented accommodation, lived with no other
adults, were not working and had a long-term limiting
illness. Conversely, individuals were more likely to be
classiﬁed as vulnerable to their chronic pain if they lived
in council-rented accommodation, lived with no other
adults, were unable to work and had a long-term limit-
ing illness. On multivariate analysis sex, age, housing,
employment and long-term limiting illness were identi-
ﬁed as the factors independently associated with being
vulnerable or resilient and were adjusted for in subse-
quent analyses.
Mortality
During the 10-year follow-up period, 21.1% of the resili-
ent group and 31.9% of the non-resilient group died
(table 2). In comparison, 32.7% of the vulnerable group
and 20.9% of the non-vulnerable group died. The main
causes of death were broadly similar in each group
(table 2).
Kaplan-Meier survival plots (ﬁgure 2) show a progressive
divergence over time between resilient and non-resilient
groups, and between vulnerable and non-vulnerable
groups, with no discontinuity. Table 2 details the results of
the Cox proportional hazards regression (expressed as
Table 1 Factors associated with being in the resilient or vulnerable groups
Non-resilient Resilient Non-vulnerable Vulnerable
N N OR (95% CI) N N OR (95% CI)
Sex
Male 630 402 716 52
Female 793 417 0.82 (0.69 to 0.98) 674 55 1.12 (0.76 to 1.67)
Age group (years)
25–34 80 68 113 10
35–44 198 113 0.67 (0.45 to 1.00) 187 15 0.91 (0.39 to 2.09)
45–54 301 173 0.68 (0.47 to 0.98) 255 14 0.62 (0.27 to 1.44)
55–64 323 172 0.63 (0.43 to 0.91) 299 24 0.91 (0.42 to 1.96)
65–74 266 172 0.76 (0.52 to 1.11) 325 23 0.80 (0.37 to 1.73)
75+ 255 121 0.56 (0.38 to 0.82) 211 21 1.12 (0.51 to 2.47)
Marital status
Single 126 80 113 12
Married/cohabit 909 587 1.02 (0.75 to 1.37) 1005 65 0.61 (0.32 to 1.16)
No longer married 367 147 0.63 (0.45 to 0.89) 253 28 1.04 (0.51 to 2.12)
Education
University 118 123 305 17
High school 260 178 0.66 (0.48 to 0.90) 335 24 1.29 (0.68 to 2.44)
No qualifications 878 470 0.51 (0.39 to 0.68) 656 60 1.64 (0.94 to 2.86)
Housing
Owned/mortgaged 663 547 977 59
Rented privately/other 62 30 0.59 (0.37 to 0.92) 64 6 1.55 (0.65 to 3.73)
Rented from council 675 236 0.42 (0.35 to 0.51) 323 40 2.05 (1.35 to 3.12)
Social support
Other adults in home 968 602 1030 68
No other adults 368 173 0.76 (0.61 to 0.93) 271 35 1.96 (1.27 to 3.00)
Employment
Working 271 386 657 34
Retired 474 270 0.40 (0.32 to 0.50) 527 42 1.54 (0.97 to 2.46)
Unable to work 504 76 0.11 (0.08 to 0.14) 38 16 8.14 (4.13 to 16.03)
Unemployed 122 66 0.38 (0.27 to 0.53) 130 11 1.64 (0.81 to 3.31)
Long-term limiting illness
No 222 420 941 23
Yes 1182 389 0.18 (0.15 to 0.22) 420 82 7.99 (4.96 to 12.86)
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HRs). After adjusting for sex, age, housing, employment
(independently associated sociodemographic factors) and
long-term limiting illness, individuals in the resilient group
were 25% less likely to die within 10 years of the survey
compared with non-resilient individuals: HR 0.75, 95% CI
0.62 to 0.91. A statistically signiﬁcant reduction in death
from cancer among the resilient group also remained (HR
0.64, 0.44 to 0.93) after adjustment. After adjustment, vul-
nerable individuals were more likely to die over the 10-year
period than non-vulnerable individuals (HR 1.45, 1.01 to
2.11) and vulnerable individuals were signiﬁcantly more
likely to die from circulatory diseases than those in the
non-vulnerable group (HR 1.91, 1.08 to 3.38).
Hospital use
Most of the individuals in each group used a hospital
service at least once during the 10-year follow-up period.
Outpatient or day-case attendance occurred in 720
(87.9%) resilient individuals, 1211 (85.1%) non-resilient
individuals, 86 (80.4%) vulnerable individuals and 1238
(89.1%) non-vulnerable individuals. At least one
inpatient admission occurred in 514 (62.8%) resilient
individuals, 1017 (71.5%) non-resilient individuals, 82
(76.6%) vulnerable individuals and 865 (62.2%) non-
vulnerable individuals.
Details of hospital use over the 10-year follow-up
period are presented in table 3 (comparing resilient and
non-resilient groups) and table 4 (comparing vulnerable
and non-vulnerable groups). Table 3 shows that com-
pared with non-resilient individuals, resilient individuals
with chronic pain were less likely to have had an out-
patient or day-case visit for anaesthetics, the speciality
which hosts pain clinics: adjusted OR 0.46, 0.27 to 0.79.
There were no other statistically signiﬁcant differences
in visits for other clinical specialities. There were no stat-
istically signiﬁcant differences in the number of out-
patient or day-case visits, nor were there any statistically
signiﬁcant differences in inpatient days between resilient
and non-resilient groups. Compared with non-vulnerable
individuals, those in the vulnerable group were signiﬁ-
cantly less likely to have any outpatient or day-case visits
(table 4: adjusted OR 0.43, 0.25 to 0.75); and more
likely to have an outpatient or day-case psychiatric visit
(OR 1.96, 1.06 to 3.61). There were no statistically sig-
niﬁcant differences in the number of outpatient or
day-case visits. No differences were observed between
vulnerable and non-vulnerable groups for likelihood of
any inpatient visits, or total number of inpatient days
(except for anaesthetics). However, the very small
number of inpatient admissions in the vulnerable group
indicates that any inference from these should be viewed
with caution.
DISCUSSION
This is the ﬁrst study to examine the long-term effects of
resilience or vulnerability to chronic pain in terms of
survival and hospital use. We found that resilience to
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chronic pain (as deﬁned by low disability in spite of
high-intensity pain) was associated with a signiﬁcantly
reduced risk of death over the subsequent 10 years. With
the exception of pain services, resilient individuals made
the same use of specialist services as the non-resilient
comparator group. We also found that individuals classi-
ﬁed as vulnerable to their chronic pain had poorer sur-
vival than those in the non-vulnerable comparison
group. The few differences between vulnerable and non-
vulnerable individuals in their use of hospital services
were related mainly to psychiatric and anaesthetic
services.
A major strength of our study was its community base.
Results from this study are more likely to be representa-
tive of people living in the community than those from
studies using samples from healthcare settings, such as
pain clinics. The prospective nature of the study meant
that pain status was ascertained before outcome was
measured, avoiding a recall bias. Furthermore, long-term
outcomes were available for analysis. We did not collect
data using a formal resilience scale,27 unlike some previ-
ous studies of chronic pain.17 18 28 The lack of standar-
dised deﬁnitions of vulnerability and resilience and the
lack of use of a formal resilience scale are limitations of
our study. Instead, our analyses assume that self-reported
pain intensity and disability due to pain correctly differ-
entiated respondents into those resilient or vulnerable
to the effects of chronic pain. Individuals were cate-
gorised based on their scores on the intensity and dis-
ability subscales of the CPG. Use of the two subscales
allowed us to use a measure of disability that was directly
related to pain, rather than use of a generic measure of
health that could have been inﬂuenced by other condi-
tions. This approach meant that the two subscales were
directly comparable. Since we did not use the ‘days off
work’ question in the CPG questionnaire normally used
to grade people, a sensitivity analysis was undertaken to
examine the effect of including this additional question.
Analysis showed that the ﬁndings did not materially
change, with the same overall pattern of results seen
(data not shown). A strength of our approach is that it
moves away from groupings based on help-seeking
behaviour which is known to be a poor marker of actual
functioning.29 30 Consulting a healthcare professional
may not always identify individuals who are ‘resilient’ or
‘vulnerable’ to their symptoms.
Resilience and vulnerability were associated with
several sociodemographic variables and we were able to
adjust for these in the analysis. Some other potentially
important factors were not fully available in the dataset,
but were examined in an additional set of sensitivity ana-
lyses to examine the effects of smoking and mental
health in relation to survival. Data on cigarette smoking
were available from a follow-up survey (conducted
4 years after baseline) for 1572 of the 3739 individuals.
There were no speciﬁc measures of mental health in the
original survey although it did include the SF-36
measure of health-related quality of life which includes a
mental health component. Adding both of these vari-
ables in turn into the survival models did not change
the HRs substantially, although incomplete data led to
wider CIs. While we found a few differences in specialist
care use between groups, our analyses did not allow for
different survival between groups, which meant that
resilient individuals tended to have a longer period of
time in which to receive specialist treatment than non-
resilient individuals; and vulnerable individuals tended
to have less time than non-vulnerable individuals. These
patterns of survivorship are likely to exaggerate the
differences between groups, rather than diminishing
them.
There is a growing interest in the phenomenon of
resilience in a range of health and social sciences. While
hard to deﬁne,11 31 32 it has been suggested that resili-
ence describes something more than either hardiness
(eg, not becoming unwell) or coping. Instead, it implies
experiencing adversity (illness) and adapting in order to
bounce back and thrive, sometimes in changed ways.33
Our ﬁnding of generally comparable healthcare use
between resilient and non-resilient individuals suggests
that resilience in our study was not simply measuring
hardiness.
Figure 2 Kaplan-Meier survival
plots comparing: (A) resilient
versus non-resilient; (B)
vulnerable versus non-vulnerable
groups.
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Table 4 Specialist (hospital) care use over a 10-year follow-up: comparison of vulnerable and non-vulnerable groups
Non-vulnerable Vulnerable
Adjusted OR*
Non-vulnerable Vulnerable
Adjusted IRR*N N (95% CI) p Value median median (95% CI) p Value
Any outpatient/day-case visit Number of outpatient/day-case visits (excluding pts with no visits)
Medicine 695 55 0.79 (0.51 to 1.22) 0.29 3 3 0.97 (0.58 to 1.64) 0.92
Surgical 1046 73 0.68 (0.43 to 1.09) 0.11 4 5 1.11 (0.79 to 1.56) 0.54
Musculoskeletal† 116 7 0.56 (0.25 to 1.26) 0.16 4 13 1.48 (0.48 to 4.53) 0.50
Oncology† 139 7 0.62 (0.28 to 1.38) 0.24 5 10 1.27 (0.46 to 3.53) 0.65
Anaesthetics† 16 4 2.45 (0.75 to 7.96) 0.14 2 1.5 6.39 (0.73 to 55.97) 0.09
Psychiatry† 107 16 1.96 (1.06 to 3.61) 0.03 2 1.5 1.45 (0.46 to 4.58) 0.52
All 1238 86 0.43 (0.25 to 0.75) 0.003 6 8 1.18 (0.88 to 1.58) 0.27
Any inpatient days Total inpatient days (excluding pts with no visits)
Medicine 579 56 1.1 (0.68 to 1.77) 0.70 12 21 1.32 (0.84 to 2.07) 0.24
Surgical 569 54 1.37 (0.89 to 2.12) 0.16 6 7 1.07 (0.68 to 1.69) 0.76
Musculoskeletal† 14 2 1.05 (0.23 to 4.86) 0.95 7.5 9 0.68 (0.24 to 1.94) 0.47
Oncology† 65 5 0.92 (0.35 to 2.40) 0.86 13 18 0.71 (0.24 to 2.04) 0.52
Anaesthetics† 28 2 0.82 (0.18 to 3.65) 0.80 3 2 0.06 (0.00 to 0.93) 0.04
Psychiatry† 27 4 1.54 (0.50 to 4.70) 0.45 123 11.5 0.29 (0.09 to 0.98) 0.05
All 865 82 1.56 (0.92 to 2.67) 0.10 13 19 1.13 (0.76 to 1.68) 0.56
*Adjusted for sex, age, housing, employment and long-term limiting illness; except where rows marked otherwise.
†Adjusted for long-term limiting illness only.
Bold font represents p<0.05.
Table 3 Specialist (hospital) care use over 10-year follow-up: comparison of resilient and non-resilient groups
Non-resilient Resilient
Adjusted OR*
Non-resilient Resilient
Adjusted IRR*N N (95% CI) p Value median median (95% CI) p Value
Any outpatient/day-case visit Number of outpatient/day-case visits (excluding pts with no visits)
Medicine 840 478 1.11 (0.90 to 1.37) 0.34 3 3 1.07 (0.86 to 1.34) 0.53
Surgical 1010 593 0.97 (0.77 to 1.23) 0.82 4 4 0.96 (0.82 to 1.12) 0.61
Musculoskeletal 204 89 0.95 (0.69 to 1.30) 0.74 4 4 1.11 (0.71 to 1.75) 0.65
Oncology 147 83 1.01 (0.72 to 1.42) 0.93 5 5 1.05 (0.65 to 1.72) 0.83
Anaesthetics 107 26 0.46 (0.27 to 0.79) 0.002 3 2 1.07 (0.44 to 2.56) 0.89
Psychiatry 155 73 1.03 (0.72 to 1.47) 0.89 3 2 0.85 (0.42 to 1.72) 0.65
All 1211 720 1.21 (0.90 to 1.64) 0.21 9 8 0.94 (0.83 to 1.07) 0.38
Any inpatient days Total inpatient days (excluding pts with no visits)
Medicine 755 373 1.02 (0.82 to 1.28) 0.84 19 15 1.01 (0.81 to 1.26) 0.90
Surgical 646 331 0.84 (0.68 to 1.03) 0.10 7 6 0.85 (0.64 to 1.11) 0.23
Musculoskeletal† 53 16 0.72 (0.39 to 1.31) 0.28 12 10 0.76 (0.38 to 1.51) 0.43
Oncology 70 49 1.06 (0.67 to 1.67) 0.80 11 15 1.58 (0.44 to 5.64) 0.48
Anaesthetics† 54 17 0.76 (0.42 to 1.36) 0.35 2 4 1.21 (0.25 to 5.88) 0.81
Psychiatry† 53 19 0.72 (0.41 to 1.27) 0.26 47 58 1.54 (0.52 to 4.59) 0.43
All 1017 514 0.80 (0.64 to 1.01) 0.06 21 17 1.06 (0.86 to 1.30) 0.60
*Analysis adjusted for sex, age, housing, employment and long-term limiting illness; except where rows marked otherwise.
†Analysis adjusted for long-term limiting illness only.
Bold font represents p<0.05.
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Whatever resilience is, and however it is measured,
our ﬁnding of better survival among resilient people
with chronic pain, suggests that resilience is a phenom-
enon worth researching. It was noteworthy that a larger
proportion (36.5%) of individuals were resilient than
vulnerable (7.1%). This suggests that important gains
may be made in understanding who is likely to become
resilient, why and how. We also need to understand
more about how resilience changes with time and what
factors inﬂuences this. While there is already some infor-
mation available regarding the traits and activities that
seem to inﬂuence resilience (such as family, mood,
social class, socioeconomic status and life events),20 34 35
further research is needed to tease out the internal and
external factors that inﬂuence an individual’s resilience.
Of particular importance will be the identiﬁcation of
modiﬁable factors that could be used to help build add-
itional resilience in individuals who could beneﬁt.
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